Vincent O'Neill - Executive Vice President, Chief of Product Development and Medical Officer at BioXcel Therapeutics, Inc.

Issuer-level insider activity

Role: Executive Vice President, Chief of Product Development and Medical Officer
Issuer symbol: BTAI on Nasdaq
Entity type: Individual
SEC filing history: Open SEC filing history

No buys or sells have been reported by Vincent O'Neill since 02 Jun 2025

Reported holdings for Vincent O'Neill in BioXcel Therapeutics, Inc.

Form 4 holding Executive Vice President, Chief of Product Development and Medical Officer

BioXcel Therapeutics, Inc.

Security class: Common Stock
Shares / value: 19,957
Estimated value: $7,031
Report date: 16 Dec 2024
Price: $0.3523
Ownership: Direct

Form 4 holding Executive Vice President, Chief of Product Development and Medical Officer

BioXcel Therapeutics, Inc.

Security class: Restricted Stock Units
Shares / value: 2,606
Estimated value: $944
Report date: 14 Dec 2024
Price: $0.3624
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Executive Vice President, Chief of Product Development and Medical Officer

BioXcel Therapeutics, Inc.

Security class: Stock Option (right to buy)
Shares / value: 1,875
Estimated value
Report date: 22 Jul 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 0

Transaction history for Vincent O'Neill in BioXcel Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .